Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic

Stroke does everyone need it?

Venkatesh Aiyagari, Arunodaya Gujjar, Allyson R. Zazulia, Michael N. Diringer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and Purpose - Blood pressure (BP) control is considered essential in patients treated with tissue plasminogen activator (tPA) for ischemic stroke, and it is recommended that BP be monitored every 15 minutes to 1 hour for 24 hours in these patients. We postulated that patients whose BP is not initially elevated are unlikely to have elevated BP later and, therefore, may not need prolonged BP monitoring. Methods - We performed a retrospective chart review of patients treated with intravenous tPA for ischemic stroke over a 3-year period. Patients with incomplete records were excluded. Results - Seventy-nine patients (35 male, age 68.8±14.3 years) were studied. Before tPA treatment, 16 patients (20%) had hypertension (systolic BP ≥185 or diastolic BP ≥110 mm Hg). All 16 patients had subsequent hypertension over the next 24 hours. Of the remaining 63, 27 patients (43%) had hypertension (systolic BP ≥180 or diastolic BP ≥105 mm Hg) within the first 6 hours. An additional 4 had minor transient systolic elevations (≤182 mm Hg) after 6 hours that normalized without treatment. Neurological worsening, seen in 13 patients (17%), was not associated with the presence of hypertension (initial or subsequent). Conclusions - In patients receiving tPA for stroke, absence of hypertension at presentation does not preclude subsequent increase in blood pressure. However, if blood pressure is not elevated during the first 6 hours, subsequent hypertension over the next 18 hours is unlikely. This study is small and retrospective, and needs to be repeated in a larger prospective cohort. However, our results provide preliminary evidence to suggest that where resources are scarce, these patients may be discharged from the intensive care unit earlier than the recommended 24 hours, provided that they are not at high risk for neurological deterioration.

Original languageEnglish
Pages (from-to)2326-2330
Number of pages5
JournalStroke
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Tissue Plasminogen Activator
Stroke
Blood Pressure
Hypertension
Intensive Care Units

Keywords

  • Blood pressure
  • Stroke
  • Stroke units
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic : Stroke does everyone need it? / Aiyagari, Venkatesh; Gujjar, Arunodaya; Zazulia, Allyson R.; Diringer, Michael N.

In: Stroke, Vol. 35, No. 10, 10.2004, p. 2326-2330.

Research output: Contribution to journalArticle

Aiyagari, Venkatesh ; Gujjar, Arunodaya ; Zazulia, Allyson R. ; Diringer, Michael N. / Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic : Stroke does everyone need it?. In: Stroke. 2004 ; Vol. 35, No. 10. pp. 2326-2330.
@article{2426f55c71244dcd8eeba59112422ef7,
title = "Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic: Stroke does everyone need it?",
abstract = "Background and Purpose - Blood pressure (BP) control is considered essential in patients treated with tissue plasminogen activator (tPA) for ischemic stroke, and it is recommended that BP be monitored every 15 minutes to 1 hour for 24 hours in these patients. We postulated that patients whose BP is not initially elevated are unlikely to have elevated BP later and, therefore, may not need prolonged BP monitoring. Methods - We performed a retrospective chart review of patients treated with intravenous tPA for ischemic stroke over a 3-year period. Patients with incomplete records were excluded. Results - Seventy-nine patients (35 male, age 68.8±14.3 years) were studied. Before tPA treatment, 16 patients (20{\%}) had hypertension (systolic BP ≥185 or diastolic BP ≥110 mm Hg). All 16 patients had subsequent hypertension over the next 24 hours. Of the remaining 63, 27 patients (43{\%}) had hypertension (systolic BP ≥180 or diastolic BP ≥105 mm Hg) within the first 6 hours. An additional 4 had minor transient systolic elevations (≤182 mm Hg) after 6 hours that normalized without treatment. Neurological worsening, seen in 13 patients (17{\%}), was not associated with the presence of hypertension (initial or subsequent). Conclusions - In patients receiving tPA for stroke, absence of hypertension at presentation does not preclude subsequent increase in blood pressure. However, if blood pressure is not elevated during the first 6 hours, subsequent hypertension over the next 18 hours is unlikely. This study is small and retrospective, and needs to be repeated in a larger prospective cohort. However, our results provide preliminary evidence to suggest that where resources are scarce, these patients may be discharged from the intensive care unit earlier than the recommended 24 hours, provided that they are not at high risk for neurological deterioration.",
keywords = "Blood pressure, Stroke, Stroke units, Tissue plasminogen activator",
author = "Venkatesh Aiyagari and Arunodaya Gujjar and Zazulia, {Allyson R.} and Diringer, {Michael N.}",
year = "2004",
month = "10",
doi = "10.1161/01.STR.0000141937.80760.10",
language = "English",
volume = "35",
pages = "2326--2330",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic

T2 - Stroke does everyone need it?

AU - Aiyagari, Venkatesh

AU - Gujjar, Arunodaya

AU - Zazulia, Allyson R.

AU - Diringer, Michael N.

PY - 2004/10

Y1 - 2004/10

N2 - Background and Purpose - Blood pressure (BP) control is considered essential in patients treated with tissue plasminogen activator (tPA) for ischemic stroke, and it is recommended that BP be monitored every 15 minutes to 1 hour for 24 hours in these patients. We postulated that patients whose BP is not initially elevated are unlikely to have elevated BP later and, therefore, may not need prolonged BP monitoring. Methods - We performed a retrospective chart review of patients treated with intravenous tPA for ischemic stroke over a 3-year period. Patients with incomplete records were excluded. Results - Seventy-nine patients (35 male, age 68.8±14.3 years) were studied. Before tPA treatment, 16 patients (20%) had hypertension (systolic BP ≥185 or diastolic BP ≥110 mm Hg). All 16 patients had subsequent hypertension over the next 24 hours. Of the remaining 63, 27 patients (43%) had hypertension (systolic BP ≥180 or diastolic BP ≥105 mm Hg) within the first 6 hours. An additional 4 had minor transient systolic elevations (≤182 mm Hg) after 6 hours that normalized without treatment. Neurological worsening, seen in 13 patients (17%), was not associated with the presence of hypertension (initial or subsequent). Conclusions - In patients receiving tPA for stroke, absence of hypertension at presentation does not preclude subsequent increase in blood pressure. However, if blood pressure is not elevated during the first 6 hours, subsequent hypertension over the next 18 hours is unlikely. This study is small and retrospective, and needs to be repeated in a larger prospective cohort. However, our results provide preliminary evidence to suggest that where resources are scarce, these patients may be discharged from the intensive care unit earlier than the recommended 24 hours, provided that they are not at high risk for neurological deterioration.

AB - Background and Purpose - Blood pressure (BP) control is considered essential in patients treated with tissue plasminogen activator (tPA) for ischemic stroke, and it is recommended that BP be monitored every 15 minutes to 1 hour for 24 hours in these patients. We postulated that patients whose BP is not initially elevated are unlikely to have elevated BP later and, therefore, may not need prolonged BP monitoring. Methods - We performed a retrospective chart review of patients treated with intravenous tPA for ischemic stroke over a 3-year period. Patients with incomplete records were excluded. Results - Seventy-nine patients (35 male, age 68.8±14.3 years) were studied. Before tPA treatment, 16 patients (20%) had hypertension (systolic BP ≥185 or diastolic BP ≥110 mm Hg). All 16 patients had subsequent hypertension over the next 24 hours. Of the remaining 63, 27 patients (43%) had hypertension (systolic BP ≥180 or diastolic BP ≥105 mm Hg) within the first 6 hours. An additional 4 had minor transient systolic elevations (≤182 mm Hg) after 6 hours that normalized without treatment. Neurological worsening, seen in 13 patients (17%), was not associated with the presence of hypertension (initial or subsequent). Conclusions - In patients receiving tPA for stroke, absence of hypertension at presentation does not preclude subsequent increase in blood pressure. However, if blood pressure is not elevated during the first 6 hours, subsequent hypertension over the next 18 hours is unlikely. This study is small and retrospective, and needs to be repeated in a larger prospective cohort. However, our results provide preliminary evidence to suggest that where resources are scarce, these patients may be discharged from the intensive care unit earlier than the recommended 24 hours, provided that they are not at high risk for neurological deterioration.

KW - Blood pressure

KW - Stroke

KW - Stroke units

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=4744376461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744376461&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000141937.80760.10

DO - 10.1161/01.STR.0000141937.80760.10

M3 - Article

VL - 35

SP - 2326

EP - 2330

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 10

ER -